₹657.05 0.05 (0.01%)
04:01 PM, 7-Jan-2026₹656.75 1.10 (0.17%)
03:51 PM, 7-Jan-2026BSE : 539268
NSE : SYNGENE
Sector : Others
ISIN Code : INE398R01022
Last Updated: 07-Jan-2026 | 04:01 PM IST
| Market Cap (₹ Cr) | 26,475 |
Traded Value (₹ Cr) | 2.77 |
Volume (Shares) | 42,219 |
Face Value (₹) | 10 |
52-Week High (₹) | 895.85 |
52-Week High Date | 10-Jan-2025 |
52-Week Low (₹) | 598.55 |
52-Week Low Date | 09-May-2025 |
All Time High (₹) | 960.00 |
All Time High Date | 02-Dec-2024 |
All Time Low (₹) | 174.50 |
All Time Low Date | 05-Apr-2016 |
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 26,463 |
| EPS - TTM (₹) [C] | 11.62 |
| P/E Ratio (X) [C] | 56.52 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 12.50 |
| Latest Dividend Date | 27-Jun-2025 |
| Dividend Yield (%) | 0.19 |
| Book Value Share (₹) [C] | 117.51 |
| P/B Ratio (₹) [C] | 5.59 |
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| UTI-Flexi Cap Fund (IDCW) | 157.67 | 24,22,041 | 0.63 |
| UTI-Flexi Cap Fund (G) | 157.67 | 24,22,041 | 0.63 |
| UTI-Flexi Cap Fund - Direct (G) | 157.67 | 24,22,041 | 0.63 |
| UTI-Flexi Cap Fund - Direct (IDCW) | 157.67 | 24,22,041 | 0.63 |
| UTI-Mid Cap Fund (IDCW) | 97.65 | 15,00,000 | 0.82 |
| UTI-Mid Cap Fund (G) | 97.65 | 15,00,000 | 0.82 |
| UTI-Mid Cap Fund - Direct (IDCW) | 97.65 | 15,00,000 | 0.82 |
| UTI-Mid Cap Fund - Direct (G) | 97.65 | 15,00,000 | 0.82 |
| UTI-Focused Fund - Direct (IDCW) | 42.32 | 6,50,000 | 1.62 |
| UTI-Focused Fund - Direct (G) | 42.32 | 6,50,000 | 1.62 |
Load more
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
| Today's Low/High (₹) | 652.35 678.95 |
| Week Low/High (₹) | 641.70 678.95 |
| Month Low/High (₹) | 623.65 678.95 |
| Year Low/High (₹) | 599.55 896.00 |
| All time Low/High (₹) | 174.50 961.00 |
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 0.90% | 0.88% | -0.30% | 0.04% |
| 1 Month | 2.78% | 2.65% | -0.88% | -0.17% |
| 3 Month | 3.81% | 3.80% | 3.70% | 4.11% |
| 6 Month | 3.33% | 3.38% | 1.82% | 2.67% |
| 1 Year | -25.18% | -25.18% | 8.65% | 10.26% |
| 3 Year | 10.19% | 10.17% | 41.84% | 46.37% |
Chairperson : Kiran Mazumdar Shaw
Non Executive Director : Catherine Patricia Rosenberg
Independent Director : Vijay Kuchroo
Lead Independent Director : Vinita Bali
Company Sec. & Compli. Officer : Priyadarshnini Mahapatra
Independent Director : Sharmila Karve
Independent Director : Kush Parmar
Independent Director : Nilanjan Roy
Independent Director : Manja Boerman
Managing Director & Chief Executive Officer : Peter John Bains
Registered Office: Biocon SEZ Biocon Park, Plot No 2 & 3 Bommasandra Inds,Bengaluru,Karnataka-560099 Ph: 91-80-68915000/67758781
1. What's the Syngene International Ltd share price today?
Syngene International Ltd share price was Rs 657.05 at 04:01 PM IST on 7th Jan 2026. Syngene International Ltd share price was up by 0.01% over the previous closing price of Rs 657.00. Syngene International Ltd share price trend:
2. How can I quickly analyse the performance of the Syngene International Ltd stock?
The performance of the Syngene International Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Syngene International Ltd?
Syngene International Ltd has a market capitalisation of Rs 26,475 crore.
4. What is Syngene International Ltd's 52-week high/low share price?
The Syngene International Ltd’s 52-week high share price is Rs 895.85 and 52-week low share price is Rs 598.55.
5. Is the Syngene International Ltd profitable?
On a consolidated basis, Syngene International Ltd reported a profit of Rs 86.70 crore on a total income of Rs 892.20 crore for the quarter ended 2025.
6. Which are Syngene International Ltd’s peers in the Others sector?
Syngene International Ltd’s top 5 peers in the Others sector are Narayana Hrudaya, Global Health, Aster DM Health., Syngene Intl., Krishna Institu., Dr Lal Pathlabs, Poly Medicure.
7. Who owns how much in Syngene International Ltd?
Key changes to the Syngene International Ltd shareholding are as follows: